PMID- 36564376 OWN - NLM STAT- MEDLINE DCOM- 20221227 LR - 20230301 IS - 2044-4052 (Electronic) IS - 2044-4052 (Linking) VI - 12 IP - 1 DP - 2022 Dec 23 TI - The effect of aging on glucose metabolism improvement after Roux-en-Y gastric bypass in type 2 diabetes rats. PG - 51 LID - 10.1038/s41387-022-00229-9 [doi] LID - 51 AB - BACKGROUND: This study aimed to investigate the effect of aging on glucose metabolism improvement after Roux-en-Y gastric bypass (RYGB) in rat models with type 2 diabetes mellitus (T2DM). METHODS: Twenty aged Goto-Kakizaki rats were randomly assigned into RYGB-A group and sham RYGB (SR-A) group, and 10 adult Goto-Kakizaki rats also accept RYGB procedures (RYGB-Y). Glucose metabolism, resting energy expenditure (REE), glucagon-like peptide-1 (GLP-1) and total bile acid level were measured. RESULTS: RYGB could significantly improve glucose metabolism in aged diabetic rats. The fasting blood glucose level in the RYGB-A group decreased from 15.8 +/- 1.1 mmol/l before surgery to 12.3 +/- 1.5 mmol/l 16 weeks after surgery (P < 0.01), and the AUC(OGTT) value decreased from 2603.9 +/- 155.4 (mmol/l) min to 2299.9 +/- 252.8 (mmol/l) min (P = 0.08). The decrease range of fasting blood glucose in the RYGB-A group was less than that in the RYGB-Y group (20.5% +/- 6.5% vs. 40.6% +/- 10.6%, P < 0.01), so is the decrease range of AUC(OGTT) value (11.6% +/- 14.8% vs. 38.5% +/- 8.3%, P < 0.01). Moreover, at the 16th postoperative week, the increase range of REE of the RYGB-A group was lower than that of the RYGB-Y group (15.3% +/- 11.1% vs. 29.1% +/- 12.1%, P = 0.04). The increased range of bile acid of the RYGB-A group was less than that of the RYGB-Y group (80.2 +/- 59.3 % vs.212.3 +/- 139.0 %, P < 0.01). The GLP-1 level of the RYGB-A group was less than that of the RYGB-Y group (12.8 +/- 3.9 pmol/L vs. 18.7 +/- 5.6 pmol/L, P = 0.02). There was no significant difference between the RYGB-A group and the RYGB-Y group in the level of the triiodothyronine level. CONCLUSIONS: RYGB could induce a glucose metabolism improvement in aged diabetic rats, and aging might moderate the effect of RYGB. CI - (c) 2022. The Author(s). FAU - Chen, Weijie AU - Chen W AD - Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Shuaifuyuan 1#, Beijing, 100730, PR China. FAU - Yin, Haixin AU - Yin H AD - Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Shuaifuyuan 1#, Beijing, 100730, PR China. FAU - Xiao, Jianchun AU - Xiao J AD - Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Shuaifuyuan 1#, Beijing, 100730, PR China. FAU - Liu, Wei AU - Liu W AD - Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Shuaifuyuan 1#, Beijing, 100730, PR China. FAU - Qu, Qiang AU - Qu Q AD - Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Shuaifuyuan 1#, Beijing, 100730, PR China. FAU - Gong, Fengying AU - Gong F AD - Department of Endocrinology, Key Laboratory of Endocrinology of the Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Shuaifuyuan 1#, Beijing, 100730, PR China. FAU - He, Xiaodong AU - He X AUID- ORCID: 0000-0002-6682-2926 AD - Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Shuaifuyuan 1#, Beijing, 100730, PR China. hxdpumch@163.com. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20221223 PL - England TA - Nutr Diabetes JT - Nutrition & diabetes JID - 101566341 RN - 0 (Blood Glucose) RN - 0 (Bile Acids and Salts) RN - 89750-14-1 (Glucagon-Like Peptide 1) SB - IM MH - Rats MH - Animals MH - *Gastric Bypass/methods MH - Blood Glucose/metabolism MH - *Diabetes Mellitus, Experimental/metabolism MH - *Diabetes Mellitus, Type 2 MH - Bile Acids and Salts MH - Glucagon-Like Peptide 1 MH - Aging PMC - PMC9789110 COIS- The authors declare no competing interests. EDAT- 2022/12/24 06:00 MHDA- 2022/12/28 06:00 PMCR- 2022/12/23 CRDT- 2022/12/23 23:15 PHST- 2021/09/27 00:00 [received] PHST- 2022/12/14 00:00 [accepted] PHST- 2022/12/01 00:00 [revised] PHST- 2022/12/23 23:15 [entrez] PHST- 2022/12/24 06:00 [pubmed] PHST- 2022/12/28 06:00 [medline] PHST- 2022/12/23 00:00 [pmc-release] AID - 10.1038/s41387-022-00229-9 [pii] AID - 229 [pii] AID - 10.1038/s41387-022-00229-9 [doi] PST - epublish SO - Nutr Diabetes. 2022 Dec 23;12(1):51. doi: 10.1038/s41387-022-00229-9.